Target intelligence / Profile preview

Isocytosine (iC)

Target
iC
Molecular classification
Pyrimidine, Nucleobase isomer, Small molecule, Other
01

Overview

Isocytosine is a pyrimidine base and a structural isomer of the naturally occurring nucleobase cytosine (PubChem CID 67531). It is chemically defined as 2-aminopyrimidin-4(1H)-one and is primarily recognized for its role in synthetic biology, where it serves as a component of expanded genetic alphabets (Wikipedia). In these artificial systems, isocytosine forms a stable base pair with isoguanine via three hydrogen bonds, distinct from the standard Watson-Crick base pairs (PubMed: 30792298). Because it is a small molecule building block rather than a protein such as an enzyme or receptor, isocytosine is not classified as a therapeutic target. There are currently no approved drugs or clinical candidates designed to modulate isocytosine, and it does not have a known direct role in the pathophysiology of human diseases. It is occasionally used in chemical research to study the tautomerism and hydrogen-bonding patterns of nucleic acid analogs. In some bacterial species, enzymes like isocytosine deaminase have been identified, which catalyze the conversion of isocytosine to uracil, but these are not targets for human medicine.

Other names
2-Aminopyrimidin-4(1H)-one2-Amino-4-hydroxypyrimidine2-Amino-4-oxopyrimidine2-Aminopyrimidin-4-olPseudocytosine
02

Mechanism of action

Not applicable as isocytosine is a small molecule nucleobase and not a therapeutic target protein.

03

Biological functions

Synthetic genetic alphabet componentNon-canonical base pairingTautomerism studyOther
04

Disease associations

Other
05

Safety considerations

Lack of therapeutic relevancePotential for incorporation into nucleic acids in experimental settings

Beyond the preview

Go deeper on Isocytosine (iC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Isocytosine (iC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call